Product Information
FT ASPIRIN EC 325 MG TABLET is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0221 per EA under NDC 70677112201. Its NADAC has been published 138 times since Jan 3, 2024.
Strength
325 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677112201
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ASPIRINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
9/5/2023
Pharmacological Classes
Price Statistics
The NADAC for FT ASPIRIN EC 325 MG TABLET has been published 138 times since Jan 3, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0221 per EA |
|---|---|
| All-time high | $0.0240 (Apr 10, 2024) |
| All-time low | $0.0197 (Jul 17, 2024) |
| 52-week high | $0.0227 |
| 52-week low | $0.0212 |
| Median price | $0.0224 |
| Average price | $0.0222 |
| Largest weekly change | +19.9% (Aug 21, 2024) |
| Weeks tracked | 138 |
| Tracking since | Jan 3, 2024 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 45% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FT ASPIRIN EC 325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FT ASPIRIN EC 325 MG TABLET, manufactured by Strategic Sourcing Services LLC, is $0.0221 per EA (NDC 70677112201), effective Aug 19, 2026.
How has the price of FT ASPIRIN EC 325 MG TABLET changed over time?
Over the history we have for it, the NADAC for FT ASPIRIN EC 325 MG TABLET has held within roughly two percent of its current level. It has been tracked across 138 weekly CMS publications since Jan 3, 2024.
What are the highest and lowest recorded NADAC prices for FT ASPIRIN EC 325 MG TABLET?
Since Jan 3, 2024, the NADAC for FT ASPIRIN EC 325 MG TABLET has ranged from a low of $0.0197 (Jul 17, 2024) to a high of $0.0240 (Apr 10, 2024), with a median of $0.0224 per EA.
Are there cheaper alternatives to FT ASPIRIN EC 325 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC ASPIRIN 325 MG TABLET, is $0.0121 per EA — about 45% below FT ASPIRIN EC 325 MG TABLET.
Who manufactures FT ASPIRIN EC 325 MG TABLET?
FT ASPIRIN EC 325 MG TABLET (NDC 70677112201) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.